Radiological Contrast Media Supply

The contract involves the supply of 24,000 units of IOHEXOL INJECTION, a radiological contrast agent essential for medical imaging procedures, with all products required to meet USP, FDA, and NDC regulatory standards to ensure safety and efficacy. The solicitation, issued under the MEDICAL SUPPLY CHAIN PHARM FSA within the Department of Defense, is structured as a subcontract and targets vendors capable of delivering bulk quantities in strict compliance with pharmaceutical and federal guidelines. The place of performance is designated as FORT BRAGG with a ZIP code of 28310, indicating the shipment destination for the contracted goods. The proposal window is limited, with the solicitation posted on July 23, 2026, and a firm deadline for responses set for July 29, 2026, allowing only a six-day window for interested parties to submit bids. The NAICS code 325412 confirms the classification under pharmaceutical and medicine manufacturing, underscoring the technical and regulatory expertise required. Bidders must ensure full adherence to federal pharmaceutical standards and be prepared to meet the Department of Defense’s logistical and compliance expectations for delivery to a military medical facility. The official bidding portal is accessible via the provided DIBBS link for submission and further details.